Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018

  15 October 2022

Antimicrobial resistance (AMR) is a major global public health concern. The main driver of AMR development is the consumption of antimicrobial agents. Overall, in the European Union/European Economic Area and the United Kingdom (EU/EEA/UK), it is estimated that nearly one third of patients admitted to acute care hospitals are receiving at least one antimicrobial agent. The European Centre for Disease Prevention and Control (ECDC) estimated that, each year, there are ca 4.5 million healthcare-associated infections (HAIs) in acute care hospitals in the EU/EEA/UK. Approximately one-third of HAIs for which a microbiological result was obtained, was associated with antimicrobial-resistant bacteria.

Further reading: Eurosurveillance
Author(s): Ria Benkő et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed